These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16004377)

  • 21. A new scope for orlistat: Effect of approved anti-obesity drug against experimental microsporidiosis.
    Abou-El-Naga IF; Said DE; Gaafar MR; Ahmed SM; El-Deeb SA
    Med Mycol; 2019 Feb; 57(2):181-195. PubMed ID: 29529254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case Report: Ocular Microsporidiosis: Case in a Patient Returning from India and Review of the Literature.
    Leroy J; Cornu M; Deleplancque AS; Bart A; Loridant S; Fréalle E; Dutoit E; Gaillot O; van Gool T; Puisieux F; Labalette P; Sendid B
    Am J Trop Med Hyg; 2018 Jul; 99(1):90-93. PubMed ID: 29692301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between in vitro and in vivo activity of levofloxacin and moxifloxacin against pneumococcal strains with different susceptibilities to fluoroquinolones.
    Huelves L; Sevillano D; Martínez-Marín C; López-Casla MT; Gracia M; Alou L; del Carmen Ponte M; Prieto J; Soriano F;
    Int J Antimicrob Agents; 2006 Apr; 27(4):294-9. PubMed ID: 16527462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of fluoroquinolones against common respiratory pathogens.
    Aydemir S; Tunger A; Cilli F
    West Indian Med J; 2006 Jan; 55(1):9-12. PubMed ID: 16755812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones.
    Pestova E; Millichap JJ; Noskin GA; Peterson LR
    J Antimicrob Chemother; 2000 May; 45(5):583-90. PubMed ID: 10797078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laboratory assessment of lomefloxacin (SC-47111) in comparison with norfloxacin.
    Edwards R; Kanematsu M; Greenwood D
    J Antimicrob Chemother; 1988 Dec; 22(6):885-90. PubMed ID: 3243736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel synthetic polyamines are effective in the treatment of experimental microsporidiosis, an opportunistic AIDS-associated infection.
    Bacchi CJ; Weiss LM; Lane S; Frydman B; Valasinas A; Reddy V; Sun JS; Marton LJ; Khan IA; Moretto M; Yarlett N; Wittner M
    Antimicrob Agents Chemother; 2002 Jan; 46(1):55-61. PubMed ID: 11751111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental microsporidiosis in immunocompetent and immunodeficient mice and monkeys.
    Didier ES; Varner PW; Didier PJ; Aldras AM; Millichamp NJ; Murphey-Corb M; Bohm R; Shadduck JA
    Folia Parasitol (Praha); 1994; 41(1):1-11. PubMed ID: 8050748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of gatifloxacin compared with gemifloxacin, moxifloxacin, trovafloxacin, ciprofloxacin and ofloxacin against uropathogens cultured from patients with complicated urinary tract infections.
    Naber KG; Hollauer K; Kirchbauer D; Witte W
    Int J Antimicrob Agents; 2000 Nov; 16(3):239-43. PubMed ID: 11091042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy.
    Scoper SV
    Adv Ther; 2008 Oct; 25(10):979-94. PubMed ID: 18836691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro pharmacodynamic activity of gatifloxacin, gemifloxacin, moxifloxacin and levofloxacin against Streptococcus pneumoniae containing specific mutations in DNA gyrase and topoisomerase IV.
    Garrison MW; Schimmels JA; Madaras-Kelly KJ
    Diagn Microbiol Infect Dis; 2003 Dec; 47(4):587-93. PubMed ID: 14711480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experimental resistance of Vibrio cholerae el tor to nalidixic acid and fluoroquinolones].
    Ryzhko IV; Tsuraeva RI; Lomov IuM; Shut'ko AG; Mishan'kin BN; Koroleva NS; Samokhodkina ED; Shcherbaniuk AI
    Antibiot Khimioter; 2000; 45(9):7-12. PubMed ID: 11057367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First characterization of a microsporidial triosephosphate isomerase and the biochemical mechanisms of its inactivation to propose a new druggable target.
    García-Torres I; De la Mora-De la Mora I; Hernández-Alcántara G; Molina-Ortiz D; Caballero-Salazar S; Olivos-García A; Nava G; López-Velázquez G; Enríquez-Flores S
    Sci Rep; 2018 Jun; 8(1):8591. PubMed ID: 29872223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii.
    Gu DX; Hu YJ; Zhou HW; Zhang R; Chen GX
    Microb Drug Resist; 2015 Jun; 21(3):345-51. PubMed ID: 25514581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
    Fernandes PB; Swanson RN
    Drugs Exp Clin Res; 1988; 14(6):375-8. PubMed ID: 3145851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene.
    Ruiz J; Marco F; Sierra JM; Aguilar L; Garcia-Mendez E; Mensa J; Jiménez De Anta MT; Vila J
    Int J Antimicrob Agents; 2003 Jul; 22(1):73-6. PubMed ID: 12842332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microsporidial disease in HIV-infected patients: a report of 42 patients and review of the literature.
    Leder K; Ryan N; Spelman D; Crowe SM
    Scand J Infect Dis; 1998; 30(4):331-8. PubMed ID: 9817510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of moxifloxacin on its target topoisomerases from Escherichia coli and Staphylococcus aureus.
    Schedletzky H; Wiedemann B; Heisig P
    J Antimicrob Chemother; 1999 May; 43 Suppl B():31-7. PubMed ID: 10382873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition.
    Takei M; Fukuda H; Kishii R; Hosaka M
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3544-7. PubMed ID: 11709337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.
    Oliveira AD; D'Azevedo PA; Francisco W
    Cornea; 2007 Feb; 26(2):194-8. PubMed ID: 17251812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.